With apologies to Scotland 🏴󠁧󠁢󠁳󠁣󠁴󠁿 for ignorance looks like similarly to England 🏴󠁧󠁢󠁥󠁮󠁧󠁿 tepotinib available independent of line; although I would recommend as 1st line treatment as discussed

BTOG does … MET podcast is now released – this is part five of a series looking at mutations in lung cancer
 
Recorded recently, I discussed MET and treatment with @tnewsomdavis.bsky.social
You can subscribe to BTOG podcasts through usual channels – just search BTOG, or listen via BTOG website.

How to get to emergency presentation patients?
Modelling of ability to “turn off” tumour analysis for some patients
Guidelines on above for Genomic labs /Pathology/Oncology

We delivered a cost-effective national service with improvements in TAT and patient care. Questions still to be answered include
Impact on treatment and outcomes
How to move to business as usual?
How to integrate results with pathology and clinical notes?

Presented today at #RCPathGenomics about NHSE cfDNA pilot. Token oncologist in the room. Not sure what @bsky.app version of a tweetorial is. Issues addressed within the pilot can be found at www.roche-images.co.uk/Genomics_Lun...

Me please 🫡

Essays funded by @astrazeneca.bsky.social

Don’t think any of others here yet

@newcastleuni.bsky.social

Quoting from Prof Simcock of MacMilllan on X in hope will be of interest to friends and colleagues on the new and better platform.
Thoughts from him, me et al.

“Can you imagine a world with zero cancer deaths? And what would it take to get there?
learn.az/6042srIWu
“

@gerryhanna.bsky.social @jia-b.bsky.social @drpeedell.bsky.social

Need somebody to set-up one of those useful starter packs to find us all and start the conversation @bsky.app . Need to get BTOG and Professor P over here too 😀